Trials / Completed
CompletedNCT00150696
Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.
Risedronate for Prevention of Osteoporosis After Spinal Cord Injury
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 38 (planned)
- Sponsor
- Toronto Rehabilitation Institute · Academic / Other
- Sex
- All
- Age
- 16 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out if Risedronate works to prevent osteoporosis after spinal cord injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Risedronate |
Timeline
- Start date
- 2000-02-01
- Completion
- 2005-11-01
- First posted
- 2005-09-08
- Last updated
- 2007-11-21
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00150696. Inclusion in this directory is not an endorsement.